Myelofibrosis Secondary to SLE and Its Reversal on Steroid Therapy
Overview
Affiliations
Reversible myelofibrosis secondary to systemic lupus erythematosus.
Reddy M, Boloor A, Thomas N BMJ Case Rep. 2023; 16(8).
PMID: 37591626 PMC: 10441047. DOI: 10.1136/bcr-2023-255229.
Anderson E, Shah B, Davidson A, Furie R Semin Arthritis Rheum. 2018; 48(1):90-104.
PMID: 29395255 PMC: 5993585. DOI: 10.1016/j.semarthrit.2017.12.004.
Haematological manifestations of lupus.
Fayyaz A, Igoe A, Kurien B, Danda D, James J, Stafford H Lupus Sci Med. 2015; 2(1):e000078.
PMID: 25861458 PMC: 4378375. DOI: 10.1136/lupus-2014-000078.
Chalayer E, Ffrench M, Cathebras P Springerplus. 2014; 3:349.
PMID: 25045617 PMC: 4101126. DOI: 10.1186/2193-1801-3-349.
Idiopathic myelofibrosis in an infant.
Bavikar R, Kulkarni R, Rathod A, Hastak M Indian J Pediatr. 2010; 78(6):734-6.
PMID: 21188553 DOI: 10.1007/s12098-010-0340-6.